全文获取类型
收费全文 | 312篇 |
免费 | 29篇 |
出版年
2023年 | 1篇 |
2022年 | 1篇 |
2021年 | 14篇 |
2020年 | 2篇 |
2019年 | 4篇 |
2018年 | 3篇 |
2017年 | 5篇 |
2016年 | 6篇 |
2015年 | 15篇 |
2014年 | 8篇 |
2013年 | 14篇 |
2012年 | 17篇 |
2011年 | 21篇 |
2010年 | 15篇 |
2009年 | 13篇 |
2008年 | 20篇 |
2007年 | 16篇 |
2006年 | 23篇 |
2005年 | 16篇 |
2004年 | 11篇 |
2003年 | 14篇 |
2002年 | 21篇 |
2001年 | 6篇 |
1999年 | 4篇 |
1998年 | 4篇 |
1997年 | 2篇 |
1996年 | 4篇 |
1995年 | 4篇 |
1994年 | 10篇 |
1993年 | 2篇 |
1992年 | 2篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1988年 | 2篇 |
1987年 | 3篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 4篇 |
1983年 | 3篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1977年 | 5篇 |
1976年 | 4篇 |
1975年 | 1篇 |
1974年 | 5篇 |
1973年 | 2篇 |
1965年 | 1篇 |
排序方式: 共有341条查询结果,搜索用时 218 毫秒
251.
Mutant DNA polymerases have become an increasingly important tool in biotechnology. The ability to examine the activity and specific properties of enzymes has a crucial role in the characterization of the enzyme. We have developed several systems for characterizing DNA polymerases that combine random mutagenesis with in vivo selection systems. However in vivo screening systems for specific properties are sometimes unavailable. The ability to quickly screen for polymerase activity has many applications, including the identification of compounds that can inhibit polymerase activity, identifying the properties of newly discovered polymerases, and engineering new biological properties into existing polymerases. These applications can both expand the knowledge of the basic science of polymerases and can further industrial efforts to identify new drugs that specifically target polymerase activity. Here we present a high-throughput in vitro assay to select for active polymerases. We show the applicability of this assay by measuring the level of activity for a set of in vitro synthesized polymerase mutants and by screening for the incorporation of a fluorescent nucleotide analog by DNA polymerases. 相似文献
252.
Antitumor effect of recombinant tumor necrosis factor-α against murine sarcomas at visceral sites: tumor size influences the response to therapy 总被引:1,自引:0,他引:1
James J. Mulé Anthony Asher Joe McIntosh Rene Lafreniere Eitan Shiloni Alan Lefor Cheryl M. Reichert Steven A. Rosenberg 《Cancer immunology, immunotherapy : CII》1988,26(3):202-208
Summary We examined the antitumor efficacy of rTNF- administration on established tumor at two visceral sites, lungs and liver. Treatment of B6 mice harboring multiple (>100 foci of 0.5 mm diameter) 10-day pulmonary macrometastases from the MCA-106 sarcoma, with dosages of rTNF- (5–10 g, single dose i. v.) that caused hemorrhagic necrosis and regression of a 6 mm MCA-106 s. c. tumor, had no impact on the number (or size) of lung nodules. Similarly, rTNF- failed to show an antitumor effect in B6 mice with advanced day 8 or 10 multiple (>100 foci of 0.5 mm diameter) hepatic metastases at single i. v. doses up to 20 g, as measured by either enumeration of residual liver nodules or survival. B6 mice injected s. c. with MCA-106 sarcoma and treated with rTNF- as a single i. v. dose on day 0, 3, 5, or 7 experienced marked tumor regression only after the day 7 rTNF- injection, when the tumor had achieved a size of 5–6 mm in diameter. Since tumor size appeared important for rTNF- susceptibility in vivo, we next induced a single hepatic tumor of the MCA-106 sarcoma by the direct injection of cells into the left lobe of the liver and treated these mice at day 10 when the nodule had achieved a size of 5–6 mm in diameter. Increasing doses of rTNF- (up to 8 g) given as a single i. v. injection resulted in increasingly greater reductions in hepatic tumor as well as significant survival benefit of the treated mice. Sites of regressing hepatic tumor exhibited central necrosis accompanied by polymorphonuclear leukocytes and lymphocytes. Collectively, these results show that rTNF- administration can mediate a significant antitumor effect on visceral tumor and suggest that tumor size is an important factor in rTNF- susceptibility not only for tumors growing at s. c. sites but also for those established at visceral sites.Howard Hughes Medical Institute Research Scholar
Abbreviations used: rTNF-, recombinant tumor necrosis factor-; B6 mice, C57BL/6 mice; MCA, 3-methylcholanthrene; HBSS, Hanks' balanced salt solution; LAK, lymphokine-activated killer; rIL-2, recombinant interleukin-2 相似文献
253.
Abstract: The involvement of platelet-activating factor (PAF) in cell damage induced by ischemia/postischemia-like conditions was studied in a hippocampus-derived cell line, HN33.11. Cells exposed to N2-saturated glucose-free HEPES-buffered saline (ischemia) for 5 h followed by 18 h of incubation in serum-free control medium (postischemia reincubation) remained 67.4 ± 2.4% viable in comparison with sham-treated cells. Analysis of DNA fragmentation in combination with Hoechst 33258 staining indicates that apoptosis is the dominant mode of cell death in the present model. PAF level during 10 h of ischemia was unchanged. However, an increase in PAF accumulation was found early during the reincubation period that followed 5 h of ischemia. Peak PAF concentrations were noted at 2 h after initiation of reincubation and rapidly declined to control level after 7 h of reincubation. Consistent with a role of PAF in mediating cell death under ischemia/postischemia reincubation in this model, the PAF antagonist BN 50739 exerted a dose-dependent protective effect. Maximal protection (85.7 ± 5.4%) of the cells from ischemia/reincubation-induced cell damage was achieved at 0.1 µM BN 50739. The PAF antagonist lacked any protective effect against ischemia-induced cell death. On the other hand, the addition of the stable PAF analogue 1-O-hexadecyl-2-N-methylcarbamyl-sn-glycero-3-phosphocholine (MC-PAF) at the onset of ischemia potentiated ischemia/reincubation-induced apoptosis—an effect that was blocked by BN 50739. Pretreatment of HN33.11 cells with the Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetic acid acetoxymethyl ester (BAPTA-AM) also provided a protective effect against ischemia/reincubation-induced cell damage. BAPTA-AM increased cell viability by 50%. Pretreatment with BAPTA-AM also decreased ischemia/reincubation-induced PAF accumulation in HN33.11 cells. The results suggest that PAF, acting via a PAF receptor, is at least in part mediating apoptosis under ischemia/postischemia-like conditions in HN33.11 cells. 相似文献
254.
Eitan Kerem Yoram M. Kalman Yaacov Yahav Tzipora Shoshani Dvora Abeliovich Amir Szeinberg Joseph Rivlin Hanna Blau Asher Tal Lea Ben-Tur Chaim Springer Arie Augarten Simon Godfrey Israela Lerer David Branski Moshe Friedman Batsheva Kerem 《Human genetics》1995,96(2):193-197
The incidence of cystic fibrosis (CF) and the frequency of disease-causing mutations varies among different ethnic and geographic populations. The Jewish population around the world is comprised of two major ethnic groups; Ashkenazi and non-Ashkenazi. The latter is further classified according to country of origin. In this study, we analyzed the incidence of CF and the distribution of CF mutations in the general Jewish population in Israel and in most of the Jewish ethnic subgroups. The disease frequency varies considerably among the latter. Among Ashkenazi Jews, the frequency of CF is 13300, which is similar to the frequency in most Caucasian populations. Among non-Ashkenazi Jews, the disease occurs at a similar frequency among Jews from Libya (12700), Georgia (12700), Greece and Bulgaria (12400), but is rare in Jews from Yemen (18800), Morocco (115000), Iraq (132000), and Iran (139000). So far, only 12 mutations have been identified in Israeli Jews, and this enables the identification of 91% of the CF chromosomes in the entire Jewish CF population. However, in each Jewish ethnic group, the disease is caused by a different repertoire of mutations. The frequency of identified mutations is high in Ashkenazi Jews (95%), and in Jews originating from Tunisia (100%), Libya (91%), Turkey (90%), and Georgia (88%). However, a lower frequency of mutations can be identified in Moroccan (85%), Egyptian (50%), and Yemenite (0%) Jews. For genetic counseling of a Jewish individual, it is necessary to calculate the residual risk according to ethnic origin. Carrier screening of healthy Jewish individuals is currently feasible for Ashkenazi Tunisian, Libyan, Turkish, and Georgian Jews. These results provide the required information for genetic counseling of Jewish CF families and screening programs of Jewish populations worldwide. 相似文献
255.
CFTR Haplotype Analysis Reveals Genetic Heterogeneity in the Etiology of Congenital Bilateral Aplasia of the Vas Deferens 总被引:8,自引:3,他引:5
下载免费PDF全文
![点击此处可从《American journal of human genetics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Naama Rave-Harel Igael Madgar Ran Goshen Malka Nissim-Rafinia Anuar Ziadni Ayelet Rahat Ornit Chiba Yoram M Kalman Chaim Brautbar David Levinson Arie Augarten Eitan Kerem Batsheva Kerem 《American journal of human genetics》1995,56(6):1359-1366
Congenital bilateral aplasia of the vas deferens (CBAVD) was suggested to be a mild form of cystic fibrosis (CF). Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in males with CBAVD revealed that in some males CBAVD is caused by two defective CFTR alleles. The genetic basis of CBAVD in the other males and its association with CF remained unclear. We undertook this study to test the hypothesis of commonality of CBAVD and CF by haplotype analysis, in the CFTR locus, of males suffering from CBAVD and of their families. According to the hypothesis of commonality of CBAVD and CF, two brothers with CBAVD are expected to carry the same two CFTR alleles, while their fertile brothers are expected to carry at least one different allele. Eleven families were studied, of which two families, with unidentified CFTR mutations, did not support this hypothesis. In these families two brothers with CBAVD inherited different CFTR alleles. Their fertile brothers inherited the same CFTR alleles as their brothers with CBAVD. These results provide evidence for genetic heterogeneity in CBAVD. Though in some families CBAVD is associated with two CFTR mutations, we suggest that in others it is caused by other mechanisms, such as mutations at other loci or homozygosity or heterozygosity for partially penetrant CFTR mutations. 相似文献
256.
Effect of Immobilization Stress on Rat Pineal β-Adrenergic Receptor-Mediated Function 总被引:1,自引:1,他引:0
The results of this investigation indicate that stress produced by immobilization alters rat pineal function. Chronic stress reduced the density of pineal beta-adrenergic receptors and the activities of the intracellular enzyme serotonin N-acetyltransferase (NAT), its product N-acetylserotonin (NAS), and the pineal hormone melatonin, which was measured during the dark phase of the diurnal lighting cycle. Removal of the adrenal medulla did not prevent the reduction of pineal beta-adrenergic receptor binding sites that is observed after chronic stress. Acute immobilization stress suppressed the dark-induced elevations of pineal NAT activity and NAS levels 10 h after the stress session without altering pineal beta-adrenergic receptor binding. Although the precise mechanisms responsible for these effects are not completely clear, the results indicate that they are related to changes in sympathetic neuronal activity and not mediated by stress-induced elevations in plasma catecholamines. 相似文献
257.
Two molecular forms of extracellular laccase induced by different phenolics were studied in Botrytis cinerea. The enzyme induced by grapejuice had a MW of 38 000 and contained 80 % sugar while that induced by gallic acid had a MW of 36 000 and contained 70 % sugar. Both forms contained arabinose, xylose, mannose, galactose and glucose but differed markedly in the relative content of these sugars. Tunicamycin, which inhibits glycosylation of peptide chains, considerably reduced the level of laccase in both hyphae and medium. The two enzyme forms differed also in their isoelectric focusing pattern and amino acid composition, the grape juice enzyme being richer in basic amino acids and poorer in acidic ones. A third form, induced by p-coumaric acid, resembled the laccase induced by gallic acid in many of its properties but was apparently not identical to it. The possible significance of the various forms in relation to the infection process by the fungus is discussed. 相似文献
258.
Suppressor cells capable of enhancing tumor growth in vivo and of abrogating a potential anti-tumor immunity in vitro are generated in C57BL/6 mice inoculated with the high-leukemogenic A-RadLV. Mice inoculated with low-leukemogenic D-RadLV do not develop suppressor cells but contain anti-tumor reactive lymphocytes that can inhibit in vivo tumor growth. Cyclophosphamide (CyF) treatment of mice inoculated with A-RadLV hampered suppressor cell function and rendered the animals' lymphocytes responsive to A-RadLV induced tumor cells in vitro. Administration of CyF also reduced leukemia incidence in mice inoculated with A-RadLV, but had no effect on leukemia induction by D-RadLV in irradiated mice. It is suggested that the high leukemogenic activity of A-RadLV depends on the virus' ability to recruit CyF-sensitive suppressor cells early in latency and that tumor progression in mice inoculated with D-RadLV is arrested due to the host immune response. 相似文献
259.
Assimilate translocation has been identified and characterized in Gracilaria cornea under different conditions. Carbon fixation and translocation were carried out by inserting the base part of the thallus into a bicarbonate labeled solution in seawater and exposing its upper part to the air (open system) or to a non-labeled solution above a rubber septum (closed system). After a pulse-chase treatment in the light, three separate sections of each thallus were extracted by DMF (high moleuclar weight photosynthates) or by ethanol (low molecular weight). The results indicate a high rate of active photosynthate translocation which is directly related to inorganic carbon gradients in the thallus, and probably also to sugar gradients in the thallus. Translocation parameters of Gracilaria cornea are lower than of brown algae, as Gracilaria does not contain specific translocation tissues. 相似文献
260.
Hoau-Yan Wang †Tian-Li Yue †‡Giora Feuerstein ‡ Eitan Friedman 《Journal of neurochemistry》1994,63(5):1720-1725
Abstract: The effect of platelet-activating factor (PAF) on neurotransmitter release from rat brain slices prelabeled with [3 H]acetylcholine ([3 H]ACh), [3 H]norepinephrine ([3 H]NE), or [3 H]serotonin ([3 H]5-HT) was studied. PAF inhibited K+ depolarization-induced [3 H]ACh release in slices of brain cortex and hippocampus by up to 59% at 10 n M but did not inhibit [3 H]ACh release in striatal slices. PAF did not affect 5-HT or NE release from cortical brain slices. The inhibition of K+ -evoked [3 H]ACh release induced by PAF was prevented by pretreating tissues with several structurally different PAF receptor antagonists. The effect of PAF was reversible and was not affected by pretreating brain slices with tetrodotoxin. PAF-induced inhibition of [3 H]ACh release was blocked 90 ± 3 and 86 ± 2% by pertussis toxin and by anti-Gαi1/2 antiserum incorporated into cortical synaptosomes, respectively. The results suggest that PAF inhibits depolarization-induced ACh release in brain slices via a Gαi1/2 protein-mediated action and that PAF may serve as a neuromodulator of brain cholinergic system. 相似文献